RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA

Clinical trials for RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy trial offers hope for HIV patients with advanced cancers

Disease control Ongoing

This is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…

Matched conditions: RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA

Get alerted when new RECURRENT DIFFERENTIATED THYROID GLAND CARCINOMA trials appear

New combo therapy trial offers hope for HIV patients with advanced cancers